3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
12
INDUSTRY
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Squamous Cell Carcinoma
1
Interventions
apatinib
2
Immunotherapy
2
Drug Therapy
2
130-nm albumin-bound paclitaxel
2
toripalimab
1
spartalizumab
1
darolutamide
1
camrelizumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiation
1
Platinum Compounds
1
Mitomycin
1
Low-Level Light Therapy
1
Lisaftoclax
1
Indocyanine Green
1
Gemcitabine
1
Everolimus
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
toripalimab
×
30 days
×
Clear all
NCT07629817
2026-06-05
HCHTOG2603
Henan Cancer Hospital
Phase 3
Not yet recruiting
1,044 enrolled